↓ Skip to main content

Quetiapine for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, April 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

twitter
10 tweeters

Citations

dimensions_citation
88 Dimensions

Readers on

mendeley
118 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Quetiapine for schizophrenia
Published in
Cochrane database of systematic reviews, April 2004
DOI 10.1002/14651858.cd000967.pub2
Pubmed ID
Authors

Manit Srisurapanont, Benchalak Maneeton, Narong Maneeton, Sudheer Lankappa, Rahul Gandhi

Abstract

Quetiapine is an atypical antipsychotic with, theoretically, a low propensity for movement disorder adverse effects. It is used for the treatment of schizophrenia and other psychoses.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Canada 1 <1%
Unknown 117 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 23 19%
Researcher 16 14%
Student > Doctoral Student 12 10%
Student > Ph. D. Student 10 8%
Other 10 8%
Other 29 25%
Unknown 18 15%
Readers by discipline Count As %
Medicine and Dentistry 40 34%
Psychology 19 16%
Nursing and Health Professions 11 9%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Social Sciences 3 3%
Other 10 8%
Unknown 27 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2017.
All research outputs
#2,932,032
of 12,100,779 outputs
Outputs from Cochrane database of systematic reviews
#3,804
of 7,978 outputs
Outputs of similar age
#24,592
of 109,934 outputs
Outputs of similar age from Cochrane database of systematic reviews
#39
of 83 outputs
Altmetric has tracked 12,100,779 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 109,934 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 83 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.